Patton Albertson Miller Group LLC Has $552,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Patton Albertson Miller Group LLC decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,508 shares of the medical instruments supplier’s stock after selling 505 shares during the quarter. Patton Albertson Miller Group LLC’s holdings in DENTSPLY SIRONA were worth $552,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bar Harbor Wealth Management bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at $4,931,000. DAVENPORT & Co LLC acquired a new position in DENTSPLY SIRONA during the 4th quarter worth about $1,220,000. Andra AP fonden grew its position in shares of DENTSPLY SIRONA by 20.3% in the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock valued at $10,340,000 after buying an additional 51,100 shares during the last quarter. Envestnet Asset Management Inc. raised its position in shares of DENTSPLY SIRONA by 98.1% during the third quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock worth $11,861,000 after acquiring an additional 171,958 shares during the last quarter. Finally, Mirabella Financial Services LLP acquired a new position in shares of DENTSPLY SIRONA in the third quarter worth approximately $802,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.4 %

NASDAQ XRAY traded up $0.39 during mid-day trading on Thursday, hitting $28.20. The company’s stock had a trading volume of 5,078,023 shares, compared to its average volume of 3,392,529. The firm has a market capitalization of $5.86 billion, a price-to-earnings ratio of -64.09, a PEG ratio of 1.24 and a beta of 1.00. The company’s 50 day simple moving average is $31.71 and its 200 day simple moving average is $32.60. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. During the same period last year, the company earned $0.39 earnings per share. The business’s revenue was down 2.6% on a year-over-year basis. Analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.27%. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

Wall Street Analyst Weigh In

Several research firms have issued reports on XRAY. The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target on the stock. Barrington Research dropped their price objective on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Finally, Evercore ISI dropped their price target on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $35.22.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.